Life sciences leaders cite similar distress drivers and expect IRA-linked pricing pressure; global pricing dynamics, competitive intensity, and payer/PBM leverage threaten pricing power while AI ROI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results